nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapy
|
Nakajima, Yuki |
|
2015 |
39 |
2 |
p. 198-203 6 p. |
artikel |
2 |
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis
|
Verstovsek, Srdan |
|
2015 |
39 |
2 |
p. 157-163 7 p. |
artikel |
3 |
Azacitidine for the treatment of relapsed and refractory AML in older patients
|
Itzykson, Raphael |
|
2015 |
39 |
2 |
p. 124-130 7 p. |
artikel |
4 |
Correlation between FLT3–ITD status and clinical, cellular and molecular profiles in promyelocytic acute leukemias
|
Souza Melo, Carolina Pereira |
|
2015 |
39 |
2 |
p. 131-137 7 p. |
artikel |
5 |
Editorial board and publication information
|
|
|
2015 |
39 |
2 |
p. IFC- 1 p. |
artikel |
6 |
Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias
|
Burmeister, Thomas |
|
2015 |
39 |
2 |
p. 242-247 6 p. |
artikel |
7 |
Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy
|
Erba, Harry P. |
|
2015 |
39 |
2 |
p. 183-191 9 p. |
artikel |
8 |
Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy
|
Chen, Tzu-Ting |
|
2015 |
39 |
2 |
p. 151-156 6 p. |
artikel |
9 |
Low efficacy and high mortality associated with clofarabine treatment of relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes
|
Roberts, Daniel A. |
|
2015 |
39 |
2 |
p. 204-210 7 p. |
artikel |
10 |
Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol
|
Cui, Lei |
|
2015 |
39 |
2 |
p. 115-123 9 p. |
artikel |
11 |
miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias
|
Riccioni, Roberta |
|
2015 |
39 |
2 |
p. 221-228 8 p. |
artikel |
12 |
[No title]
|
Bennett, John M. |
|
2015 |
39 |
2 |
p. 263- 1 p. |
artikel |
13 |
One day at a time: Improving the patient experience during and after intensive chemotherapy for younger and older AML patients
|
Ghodraty-Jabloo, Vida |
|
2015 |
39 |
2 |
p. 192-197 6 p. |
artikel |
14 |
Optimal time-points for minimal residual disease monitoring change on the basis of the method used in patients with acute myeloid leukemia who underwent allogeneic stem cell transplantation: A comparison between multiparameter flow cytometry and Wilms’ tumor 1 expression
|
Rossi, Giovanni |
|
2015 |
39 |
2 |
p. 138-143 6 p. |
artikel |
15 |
PDGFB hypomethylation is a favourable prognostic biomarker in primary myelofibrosis
|
Augello, Claudia |
|
2015 |
39 |
2 |
p. 236-241 6 p. |
artikel |
16 |
Pilot study of erlotinib in patients with acute myeloid leukemia
|
Sayar, Hamid |
|
2015 |
39 |
2 |
p. 170-172 3 p. |
artikel |
17 |
Quantitative analysis of CDKN2A methylation, mRNA, and p16INK4a protein expression in children and adolescents with Burkitt lymphoma: Biological and clinical implications
|
Robaina, Marcela Cristina S. |
|
2015 |
39 |
2 |
p. 248-256 9 p. |
artikel |
18 |
Statin use has negative clinical impact on non-germinal center in patients with diffuse large B cell lymphoma in rituximab era
|
Song, Moo-Kon |
|
2015 |
39 |
2 |
p. 211-215 5 p. |
artikel |
19 |
Tea consumption reduces the risk of de novo myelodysplastic syndromes
|
Liu, Ping |
|
2015 |
39 |
2 |
p. 164-169 6 p. |
artikel |
20 |
The bone marrow microenvironment is a critical player in the NK cell response against acute myeloid leukaemia in vitro
|
Vasold, Jochen |
|
2015 |
39 |
2 |
p. 257-262 6 p. |
artikel |
21 |
The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome
|
Wu, Ping |
|
2015 |
39 |
2 |
p. 216-220 5 p. |
artikel |
22 |
The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia
|
Cheng, Yuping |
|
2015 |
39 |
2 |
p. 144-150 7 p. |
artikel |
23 |
The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
|
Dinmohamed, Avinash G. |
|
2015 |
39 |
2 |
p. 177-182 6 p. |
artikel |
24 |
Thymineless death in F10-treated AML cells occurs via lipid raft depletion and Fas/FasL co-localization in the plasma membrane with activation of the extrinsic apoptotic pathway
|
Gmeiner, William H. |
|
2015 |
39 |
2 |
p. 229-235 7 p. |
artikel |
25 |
Tolerability of induction chemotherapy dosing practices in acute myeloid leukemia patients
|
Peric, Kaylene M. |
|
2015 |
39 |
2 |
p. 173-176 4 p. |
artikel |